AEON Biopharma, Inc.
AEON
$0.4304
-$0.0296-6.44%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.00K | 537.00K | 3.44M | 1.56M | 5.16M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.58M | 1.83M | 577.00K | 940.00K | 1.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.59M | 2.37M | 4.02M | 2.50M | 6.22M |
|
|
|||||
| Total Current Assets | 1.59M | 2.37M | 4.02M | 2.50M | 6.22M |
| Net Property, Plant & Equipment | 1.52M | 1.60M | 1.69M | 505.00K | 594.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.00K | 29.00K | 29.00K | 29.00K | 29.00K |
| Total Assets | 3.14M | 4.00M | 5.73M | 3.03M | 6.85M |
|
|
|||||
| Total Accounts Payable | 5.91M | 4.63M | 3.03M | 6.52M | 3.39M |
| Total Accrued Expenses | 8.12M | 5.97M | 7.27M | 6.23M | 9.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 121.00K | 128.00K | 134.00K | 205.00K | 278.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 3.00M | -- |
| Total Other Current Liabilities | -- | -- | -- | 3.00M | -- |
| Total Current Liabilities | 14.15M | 10.73M | 10.43M | 15.96M | 13.05M |
|
|
|||||
| Total Current Liabilities | 14.15M | 10.73M | 10.43M | 15.96M | 13.05M |
| Long-Term Debt | 11.69M | 15.17M | 13.29M | 5.09M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.15M | 1.20M | 1.26M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.73M | 8.99M | 8.70M | 180.37M | 146.84M |
| Total Liabilities | 31.71M | 36.09M | 33.68M | 201.41M | 159.89M |
|
|
|||||
| Common Stock & APIC | 403.03M | 401.59M | 399.56M | 393.24M | 381.27M |
| Retained Earnings | -431.60M | -433.68M | -427.51M | -591.62M | -473.60M |
| Treasury Stock & Other | -- | -- | -- | -- | -60.71M |
| Total Common Equity | -28.57M | -32.09M | -27.95M | -198.38M | -153.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.57M | -32.09M | -27.95M | -198.38M | -153.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.57M | -32.09M | -27.95M | -198.38M | -153.04M |
|
|
|||||